Lasmiditan for acute treatment of migraine in patients with cardiovascular risk factors: post-hoc analysis of pooled results from 2 randomized, double-blind, placebo-controlled, phase 3 trials

[1] Buse DC(2009)Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life Mayo Clin Proc 84 422-435

[2] Rupnow MF(2007)Indirect cost burden of migraine in the United States J Occup Environ Med 49 368-374

[3] Lipton RB(2017)Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 Lancet 390 1211-1259

[4] Hawkins K(2017)Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study BMJ 357 j2099-291

[5] Wang S(2018)Migraine and the risk of cardiovascular and cerebrovascular events: a meta-analysis of 16 cohort studies including 1 152 407 subjects BMJ Open 8 e020498-1384

[6] Rupnow MF(2016)Migraine and risk of cardiovascular disease in women: prospective cohort study BMJ 353 i2610-1011

[7] Hippisley-Cox J(2006)Migraine and risk of cardiovascular disease in women JAMA 296 283-335

[8] Coupland C(2007)Migraine and the risk of stroke, TIA, or death in the UK (CME) Headache 47 1374-635

[9] Brindle P(2015)Migraine and risk of ischaemic heart disease: a systematic review and meta-analysis of observational studies Eur J Neurol 22 1001-762

[10] Mahmoud AN(2017)Migraine and incidence of ischemic stroke: a nationwide population-based study Cephalalgia 37 327-20

[1] Buse DC(2009)Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life Mayo Clin Proc 84 422-435

[2] Rupnow MF(2007)Indirect cost burden of migraine in the United States J Occup Environ Med 49 368-374

[3] Lipton RB(2017)Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 Lancet 390 1211-1259

[4] Hawkins K(2017)Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study BMJ 357 j2099-291

[5] Wang S(2018)Migraine and the risk of cardiovascular and cerebrovascular events: a meta-analysis of 16 cohort studies including 1 152 407 subjects BMJ Open 8 e020498-1384

[6] Rupnow MF(2016)Migraine and risk of cardiovascular disease in women: prospective cohort study BMJ 353 i2610-1011

[7] Hippisley-Cox J(2006)Migraine and risk of cardiovascular disease in women JAMA 296 283-335

[8] Coupland C(2007)Migraine and the risk of stroke, TIA, or death in the UK (CME) Headache 47 1374-635

[9] Brindle P(2015)Migraine and risk of ischaemic heart disease: a systematic review and meta-analysis of observational studies Eur J Neurol 22 1001-762

[10] Mahmoud AN(2017)Migraine and incidence of ischemic stroke: a nationwide population-based study Cephalalgia 37 327-20